Showing results (901-910 of 929) with videos related to
Sort By:
Pageof 93
Eclinicalmedicine|June 14, 2019
Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC TrialCrystal M Cooper, Cherise R Chin Fatt, Manish Jha, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 13, 2015
Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC StudyChristian A Webb, Daniel G Dillon, Pia Pechtel, et al.Journal of Affective Disorders|February 1, 2019
Anxiety and anhedonia in depression: Associations with neuroticism and cognitive controlAllen Liao, Robrina Walker, Thomas J Carmody, et al.Psychotherapy and Psychosomatics|October 19, 2020
What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert ConsensusAndrea W M Evers, Luana Colloca, Charlotte Blease, et al.Psychotherapy and Psychosomatics|June 13, 2018
Implications of Placebo and Nocebo Effects for Clinical Practice: Expert ConsensusAndrea W M Evers, Luana Colloca, Charlotte Blease, et al.Plos One|May 12, 2015
Accounting for Dynamic Fluctuations across Time when Examining fMRI Test-Retest Reliability: Analysis of a Reward Paradigm in the EMBARC StudyHenry W Chase, Jay C Fournier, Tsafrir Greenberg, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 8, 2020
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?Seetal Dodd, Michael Bauer, Andre F Carvalho, et al.The Journal of Clinical Psychiatry|June 25, 2024
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled TrialMaurizio Fava, Stephen M Stahl, Luca Pani, et al.Journal of Psychiatric Research|April 25, 2018
Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC studyJoseph M Trombello, Diego A Pizzagalli, Myrna M Weissman, et al.Psychological Medicine|July 3, 2018
Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC studyChristian A Webb, Madhukar H Trivedi, Zachary D Cohen, et al.Pageof 93